A primer set, reagent and/or kit, system and application thereof for detecting lung cancer chemotherapy-related genes
A technology for detecting reagents and primer sets, which is applied in the field of primer sets for detecting lung cancer chemotherapy-related genes, can solve the problems of inability to detect unknown mutations, low throughput of in situ hybridization, high probe prices, etc. Ease of analysis and high sensitivity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0047] Example 1 Primer Design Optimization
[0048] 1) Primer sequence optimization
[0049] According to the site in Table 1, the present invention comprehensively designs PCR primers and single-base extension primers based on software and design experience, uses gDNA as a template to detect the working efficiency of primers, and finally screens out the best PCR primers and single-base extension primers through multiple rounds of design and repeated optimization. For base extension primers, see the primer sequences in Tables 2 and 3 for details.
[0050] Table 2. PCR primer sequences
[0051]
[0052]
[0053] Table 3. Single-point extension primer sequences
[0054]
[0055]
[0056] 2) Optimization of annealing temperature system
[0057] The annealing temperature is an important parameter in the reaction system. During the experiment, it was found that when the annealing temperature of the PCR reaction was set at 56°C as usual, the amplification efficiency ...
Embodiment 2
[0058] Embodiment 2 system verification
[0059] The verification of the system of the present invention includes accuracy, specificity, sensitivity, precision and comparison between personnel, etc., specifically:
[0060] The accuracy verification scheme of the present invention: each site detects 20 cases, compared with Sanger sequencing, the expected target is 95%.
[0061] The specificity verification scheme of the present invention: included in the accuracy, the expected target is 95%.
[0062] The sensitive verification scheme of the present invention: included in the accuracy, the expected target is 95%.
[0063] The precision verification scheme of the present invention (including intra-batch, inter-batch, and personnel comparison, not involving inter-instrument comparison) has an expected target of 95%.
[0064] Intra-assay precision: each sample was repeated 3 times in the same batch, and the intra-assay precision was compared:
[0065] Batch-to-batch precision: t...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com